ZoomMed (ZMD) Stock Price, News & Analysis

Company Overview

ZoomMed Inc., together with its subsidiaries, develops and markets a range of computer applications designed for healthcare professionals primarily in the United States and the United Kingdom. The company builds and operates a clinical information exchange platform between physicians, pharmacists, and various other stakeholders of the healthcare sector, such as pharmacists, specialists, pharmaceutical companies, laboratories, physiotherapy clinics, and other organizations. It also offers ZRx Prescriber, a technological Web application that enables physicians to generate prescriptions. ZoomMed Inc. was incorporated in 2005 and is headquartered in Brossard, Canada.

Key Stats

• Today's Range: C$0.02 to C$0.02
• 50-Day Range: C$0.02 to C$0.02
• 52-Week Range: C$0.01 to C$0.05
• Volume: 220,000 shs
• Average Volume: 290,486 shs
• Market Capitalization: C$2.03 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ZMD Stock Analysis - Frequently Asked Questions

How have ZMD shares performed this year?

ZoomMed's stock was trading at C$0.02 at the beginning of 2025. Since then, ZMD stock has increased by 0.0% and is now trading at C$0.02.
View the best growth stocks for 2025 here.

How do I buy shares of ZoomMed?

Shares of ZMD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Computer and Technology
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: CVE:ZMD
• CIK: N/A
• Web: zoommedcorpo.com
• Phone: +1-450-6785457
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.01
• Quick Ratio: 0.01

Sales & Book Value

• Annual Sales: C$10,000.00
• Price / Sales: 203.39
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: C($0.02) per share
• Price / Book: -0.88

Miscellaneous

• Outstanding Shares: 135,591,000
• Free Float: N/A
• Market Cap: C$2.03 million
• Optionable: Not Optionable
• Beta: N/A